Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression

Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants o...

Full description

Saved in:
Bibliographic Details
Published inBMC pharmacology Vol. 3; no. 1; p. 16
Main Authors Mukherjee, Sumanta, Banerjee, Sanjay Kumar, Maulik, Mohua, Dinda, Amit Kumar, Talwar, Kewal K, Maulik, Subir Kumar
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 20.12.2003
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity. Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury. It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression.
AbstractList Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity. Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury. It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression.
BACKGROUND: Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity. RESULTS: Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-α (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-α expression in the myocardium and was associated with reduced myocyte injury. CONCLUSIONS: It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-α expression.
Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.BACKGROUNDOxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury.RESULTSRats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury.It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression.CONCLUSIONSIt is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression.
ArticleNumber 16
Author Talwar, Kewal K
Mukherjee, Sumanta
Maulik, Mohua
Dinda, Amit Kumar
Maulik, Subir Kumar
Banerjee, Sanjay Kumar
AuthorAffiliation 2 Department of Pathology, All India Institute of Medical sciences, New Delhi – 110029 India
3 Department of Cardiology, All India Institute of Medical sciences, New Delhi – 110029 India
1 Department of Pharmacology, All India Institute of Medical sciences, New Delhi – 110029 India
AuthorAffiliation_xml – name: 3 Department of Cardiology, All India Institute of Medical sciences, New Delhi – 110029 India
– name: 1 Department of Pharmacology, All India Institute of Medical sciences, New Delhi – 110029 India
– name: 2 Department of Pathology, All India Institute of Medical sciences, New Delhi – 110029 India
Author_xml – sequence: 1
  givenname: Sumanta
  surname: Mukherjee
  fullname: Mukherjee, Sumanta
– sequence: 2
  givenname: Sanjay Kumar
  surname: Banerjee
  fullname: Banerjee, Sanjay Kumar
– sequence: 3
  givenname: Mohua
  surname: Maulik
  fullname: Maulik, Mohua
– sequence: 4
  givenname: Amit Kumar
  surname: Dinda
  fullname: Dinda, Amit Kumar
– sequence: 5
  givenname: Kewal K
  surname: Talwar
  fullname: Talwar, Kewal K
– sequence: 6
  givenname: Subir Kumar
  surname: Maulik
  fullname: Maulik, Subir Kumar
BackLink https://www.ncbi.nlm.nih.gov/pubmed/14687418$$D View this record in MEDLINE/PubMed
BookMark eNp1Ustu1DAUtVARfcCWJfKKXYodJ3aCxKKqaEGqAKGytvy4nhol9mAnaOYT-Bx-pN-Ew5TSgrq69r3nceXjQ7QXYgCEnlNyTGnHX9FG0KquKalYRfkjdHDb2Ltz3keHOX8lhIquEU_QPm14JxraHaAfn1KcwEw-BqxWyoc8YWXmCbCyyatxa3yofLCzAYuNStbHKW688dMW6y1eqTR48xp_jgPg6DAEG1cQ4pyxCkV0422py8ViH6689r-dCvLyw1l1_RPDZp0g59J8ih47NWR4dlOP0Jezt5en76qLj-fvT08uKs3ajleCEWcpqNq6vm1b5rhzWhDbcQatEFrURjS6ZT1XNTje986RroHWdc71jGh2hN7sdNezHsEaCFNSg1wnP6q0lVF5eX8S_JVcxe-S1U1DaOGf7Pjaxwf49ycmjnJJQi5JSCYpLxovb3ZI8dsMeZKjzwaGQQUobycFbQWnoi_AF3eXvXX5E2ABHO8AJsWcE7i_ECKXH_K_dfMPoWSpllTKsn54iPYLPyXD6w
CitedBy_id crossref_primary_10_1016_j_bcp_2013_07_005
crossref_primary_10_2298_HEMIND0803197I
crossref_primary_10_1007_s11033_007_9112_4
crossref_primary_10_1016_j_cbi_2019_03_012
crossref_primary_10_3390_ijms26010387
crossref_primary_10_1016_j_niox_2012_03_004
crossref_primary_10_3136_fstr_25_449
crossref_primary_10_1111_cas_12186
crossref_primary_10_1177_0960327115627685
crossref_primary_10_3389_fphar_2019_01030
crossref_primary_10_3923_ijp_2008_466_471
crossref_primary_10_1093_jn_nxaa144
crossref_primary_10_1080_15376516_2021_1965274
crossref_primary_10_3109_13880209_2010_517758
crossref_primary_10_1002_cbf_2907
crossref_primary_10_1016_j_fct_2010_01_005
crossref_primary_10_2478_sjecr_2018_0019
crossref_primary_10_1097_CRD_0b013e3181b8e4c8
crossref_primary_10_1210_en_2013_1399
crossref_primary_10_1007_s12011_010_8875_y
crossref_primary_10_1007_s11010_005_5905_8
crossref_primary_10_1016_j_soncn_2005_04_004
crossref_primary_10_1139_Y09_051
crossref_primary_10_12659_MSM_881711
crossref_primary_10_1007_s00210_020_01991_2
crossref_primary_10_1002_mnfr_200700078
crossref_primary_10_1016_j_etap_2018_01_007
crossref_primary_10_7314_APJCP_2013_14_11_6379
crossref_primary_10_1021_jf0518002
crossref_primary_10_1016_j_nut_2011_08_006
crossref_primary_10_1039_C6FO00423G
crossref_primary_10_3390_nu15153402
crossref_primary_10_1007_s10549_011_1693_x
crossref_primary_10_3844_ajptsp_2010_103_108
crossref_primary_10_1152_japplphysiol_00776_2009
crossref_primary_10_1080_22297928_2019_1708789
crossref_primary_10_1007_s11010_013_1830_4
crossref_primary_10_1089_ars_2011_3965
crossref_primary_10_1161_CIRCULATIONAHA_121_058411
crossref_primary_10_1007_s10753_017_0680_8
crossref_primary_10_1016_j_jff_2022_105212
crossref_primary_10_3389_fcvm_2022_921609
crossref_primary_10_1111_j_1365_2613_2007_00561_x
crossref_primary_10_1002_mnfr_201500656
crossref_primary_10_1016_j_ijcard_2006_01_010
crossref_primary_10_1080_10520295_2019_1647457
crossref_primary_10_1097_00029330_200608010_00009
crossref_primary_10_1177_1753944713516532
crossref_primary_10_1097_ACO_0b013e3281f8d0eb
crossref_primary_10_1039_C3FO60292C
crossref_primary_10_1007_s10565_007_9016_z
crossref_primary_10_3390_plants11151920
crossref_primary_10_1016_j_bbrc_2015_10_126
crossref_primary_10_1155_2016_1320365
crossref_primary_10_1152_ajprenal_00183_2022
crossref_primary_10_2298_AVB0806583C
crossref_primary_10_1016_j_fct_2009_02_007
crossref_primary_10_1186_1475_2891_3_10
crossref_primary_10_3390_nu15112510
crossref_primary_10_1097_01_EHX_0000444077_09624_b1
crossref_primary_10_1139_Y10_071
crossref_primary_10_1007_s10068_015_0083_2
crossref_primary_10_1007_s00262_011_1117_0
crossref_primary_10_3390_antiox11010048
crossref_primary_10_3109_01480545_2011_598531
crossref_primary_10_1089_ars_2009_2947
crossref_primary_10_1177_153303460800700102
crossref_primary_10_1684_bdc_2013_1741
crossref_primary_10_1517_14740338_5_6_791
crossref_primary_10_1016_j_fshw_2013_01_002
crossref_primary_10_18081_ajbm_2333_5106_013_12_23_27
crossref_primary_10_3390_antiox10030338
crossref_primary_10_1016_j_fct_2010_04_007
crossref_primary_10_29333_ejgm_82791
crossref_primary_10_1007_s11130_005_5103_x
crossref_primary_10_3109_0886022X_2011_589952
crossref_primary_10_1177_0960327113493304
crossref_primary_10_3892_mmr_2013_1554
crossref_primary_10_1016_j_biopha_2017_04_033
crossref_primary_10_1152_ajplung_00264_2010
crossref_primary_10_1139_cjpp_2012_0315
crossref_primary_10_1016_j_coph_2022_102187
crossref_primary_10_1016_j_fct_2010_02_008
crossref_primary_10_1016_j_jff_2017_12_008
crossref_primary_10_3109_13880209_2015_1070879
crossref_primary_10_1016_j_jsps_2021_06_004
crossref_primary_10_1155_2013_934239
crossref_primary_10_1007_s10616_014_9695_2
crossref_primary_10_1080_15569543_2021_1912099
crossref_primary_10_1016_j_ijcard_2010_04_008
crossref_primary_10_1007_s10238_011_0165_2
crossref_primary_10_1007_s00394_021_02482_7
crossref_primary_10_1179_1351000214Y_0000000088
crossref_primary_10_1139_y11_020
crossref_primary_10_1017_S0007114507793911
crossref_primary_10_1007_s10735_024_10235_z
crossref_primary_10_1016_j_jpurol_2013_03_010
Cites_doi 10.1016/B978-0-12-091302-2.50032-3
10.1016/S0024-3205(98)00302-6
10.1006/phrs.2000.0769
10.1016/0003-2697(79)90738-3
10.1161/01.CIR.97.14.1382
10.1177/40.8.1377736
10.1016/S0076-6879(81)77046-0
10.1016/0005-2760(82)90251-X
10.1016/0003-9861(59)90090-6
10.1080/01635589409514341
10.1016/S0003-4975(97)01297-6
10.1042/bj1280147
10.1016/S0021-9258(17)35746-0
10.1161/01.RES.84.4.392
10.7326/0003-4819-80-2-249
10.1177/106002809402800912
10.1073/pnas.88.12.5360
10.1161/01.RES.81.4.627
10.1016/S0022-2828(08)80008-9
10.1161/01.CIR.91.1.10
10.1016/S0024-3205(01)01514-4
10.1139/y87-305
10.1186/1471-2210-2-16
10.1056/NEJM199704103361506
10.1161/01.RES.79.2.162
10.1248/bpb.22.698
ContentType Journal Article
Copyright Copyright © 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
Copyright_xml – notice: Copyright © 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1186/1471-2210-3-16
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1471-2210
EndPage 16
ExternalDocumentID PMC324401
oai_biomedcentral_com_1471_2210_3_16
14687418
10_1186_1471_2210_3_16
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
23N
2VQ
2WC
4.4
53G
6J9
AAFWJ
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
ADUKV
AHBYD
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BFQNJ
BMC
C1A
C6C
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
EMB
EMOBN
F5P
HH5
HYE
IAO
IHR
INH
INR
KQ8
M48
MK0
ML~
O5R
O5S
OK1
OVT
P2P
PGMZT
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
W2D
WOQ
WOW
XSB
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
ABVAZ
AFGXO
AFNRJ
5PM
ID FETCH-LOGICAL-b3586-730fd1ea2df95553f6ffb70d863e577b72c74b5396a2ef699ff084e5f8ff930b3
IEDL.DBID M48
ISSN 1471-2210
IngestDate Thu Aug 21 18:20:31 EDT 2025
Wed May 22 07:12:33 EDT 2024
Fri Jul 11 05:23:47 EDT 2025
Sat Sep 28 07:43:53 EDT 2024
Tue Jul 01 02:10:14 EDT 2025
Thu Apr 24 23:02:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b3586-730fd1ea2df95553f6ffb70d863e577b72c74b5396a2ef699ff084e5f8ff930b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1471-2210-3-16
PMID 14687418
PQID 71576179
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_324401
biomedcentral_primary_oai_biomedcentral_com_1471_2210_3_16
proquest_miscellaneous_71576179
pubmed_primary_14687418
crossref_primary_10_1186_1471_2210_3_16
crossref_citationtrail_10_1186_1471_2210_3_16
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-12-20
2003-Dec-20
20031220
PublicationDateYYYYMMDD 2003-12-20
PublicationDate_xml – month: 12
  year: 2003
  text: 2003-12-20
  day: 20
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pharmacology
PublicationTitleAlternate BMC Pharmacol
PublicationYear 2003
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References LA Krishenbaum (50_CR8) 1993; 265
SE Steare (50_CR9) 1995; 276
H Okhawa (50_CR17) 1979; 95
D Harman (50_CR32) 1991; 88
DR Meldrum (50_CR14) 1998; 65
RH Blum (50_CR1) 1974; 80
C Kupatt (50_CR15) 1999; 84
B Halliwell (50_CR31) 1989
JR Neely (50_CR16) 1972; 1
SY Saad (50_CR27) 2001; 43
KJ Davies (50_CR24) 1986; 261
CF Seifert (50_CR7) 1994; 28
SK Banerjee (50_CR12) 2002; 70
N Siveski-Iliskovic (50_CR10) 1995; 91
A Wendel (50_CR21) 1981; 77
M Itosuro (50_CR22) 1998; 63
MA Bogoyevitch (50_CR35) 1996; 79
LK Annikki (50_CR23) 1992; 40
B Rietz (50_CR11) 1995; 134
K Sugioka (50_CR25) 1982; 713
S Koima (50_CR2) 1993; 266
B Bozkunt (50_CR34) 1998; 97
H Aebi (50_CR4) 1974
P Kakkar (50_CR20) 1984; 21
PJ Barnes (50_CR36) 1997; 336
GL Ellman (50_CR18) 1959; 82
H Aebi (50_CR19) 1974
ME Billingham (50_CR3) 1978; 62
T Hemnani (50_CR30) 1998; 42
C Mayer (50_CR5) 1983; 10
R Kojima (50_CR29) 1994; 22
SK Banerjee (50_CR13) 2002; 2
LE Weinberg (50_CR26) 1987; 65
T Kubota (50_CR33) 1997; 81
I Morishima (50_CR28) 1998; 63
Y Nagata (50_CR6) 1999; 22
12182765 - BMC Pharmacol. 2002 Aug 16;2:16
7329310 - Methods Enzymol. 1981;77:325-33
9314845 - Circ Res. 1997 Oct;81(4):627-35
2052612 - Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5360-3
8371168 - J Pharmacol Exp Ther. 1993 Sep;266(3):1699-704
9485242 - Ann Thorac Surg. 1998 Feb;65(2):439-43
36810 - Anal Biochem. 1979 Jun;95(2):351-8
6340204 - Semin Oncol. 1983 Mar;10(1 Suppl 1):53-5
7803884 - Ann Pharmacother. 1994 Sep;28(9):1063-72
10874342 - Indian J Physiol Pharmacol. 1998 Oct;42(4):440-52
667860 - Cancer Treat Rep. 1978 Jun;62(6):865-72
10443465 - Biol Pharm Bull. 1999 Jul;22(7):698-702
9091804 - N Engl J Med. 1997 Apr 10;336(15):1066-71
11401411 - Pharmacol Res. 2001 Mar;43(3):211-8
11895102 - Life Sci. 2002 Feb 15;70(13):1509-18
10066673 - Circ Res. 1999 Mar 5;84(4):392-400
13650640 - Arch Biochem Biophys. 1959 May;82(1):70-7
9577950 - Circulation. 1998 Apr 14;97(14):1382-91
6295497 - Biochim Biophys Acta. 1982 Nov 12;713(2):333-43
6490072 - Indian J Biochem Biophys. 1984 Apr;21(2):130-2
3456345 - J Biol Chem. 1986 Mar 5;261(7):3060-7
9718077 - Life Sci. 1998;63(7):511-21
7598835 - Boll Chim Farm. 1995 Feb;134(2):69-76
14502845 - Nutr Cancer. 1994;22(2):163-73
5085551 - Biochem J. 1972 Jun;128(1):147-59
3690411 - Can J Physiol Pharmacol. 1987 Sep;65(9):1957-65
4590654 - Ann Intern Med. 1974 Feb;80(2):249-59
8755992 - Circ Res. 1996 Aug;79(2):162-73
7805190 - Circulation. 1995 Jan 1;91(1):10-5
1377736 - J Histochem Cytochem. 1992 Aug;40(8):1203-10
7760384 - J Mol Cell Cardiol. 1995 Jan;27(1):65-74
8368352 - Am J Physiol. 1993 Aug;265(2 Pt 2):H484-93
References_xml – start-page: 673
  volume-title: In: Methods of Enzymatic Analysis
  year: 1974
  ident: 50_CR4
  doi: 10.1016/B978-0-12-091302-2.50032-3
– volume: 266
  start-page: 1699
  year: 1993
  ident: 50_CR2
  publication-title: J Pharmacol Exp Ther
– volume: 63
  start-page: 511
  year: 1998
  ident: 50_CR22
  publication-title: Life Sci
  doi: 10.1016/S0024-3205(98)00302-6
– volume: 43
  start-page: 211
  issue: 3
  year: 2001
  ident: 50_CR27
  publication-title: Pharmacol Res
  doi: 10.1006/phrs.2000.0769
– volume: 63
  start-page: 511
  issue: 7
  year: 1998
  ident: 50_CR28
  publication-title: Life Sci
  doi: 10.1016/S0024-3205(98)00302-6
– volume: 62
  start-page: 865
  year: 1978
  ident: 50_CR3
  publication-title: Cancer Treat Rep
– volume: 265
  start-page: H484
  year: 1993
  ident: 50_CR8
  publication-title: Am J Physiol
– volume: 95
  start-page: 351
  year: 1979
  ident: 50_CR17
  publication-title: Annals of Biochemistry
  doi: 10.1016/0003-2697(79)90738-3
– volume: 134
  start-page: 69
  year: 1995
  ident: 50_CR11
  publication-title: Boll Chim Farm
– volume: 42
  start-page: 440
  year: 1998
  ident: 50_CR30
  publication-title: Ind J Physiol Pharmacol
– volume: 97
  start-page: 1382
  year: 1998
  ident: 50_CR34
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.14.1382
– volume: 40
  start-page: 1203
  issue: 8
  year: 1992
  ident: 50_CR23
  publication-title: J Histochem Cytochem
  doi: 10.1177/40.8.1377736
– volume: 77
  start-page: 325
  year: 1981
  ident: 50_CR21
  publication-title: Methods in Enzymology
  doi: 10.1016/S0076-6879(81)77046-0
– volume: 713
  start-page: 333
  issue: 2
  year: 1982
  ident: 50_CR25
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2760(82)90251-X
– volume: 82
  start-page: 70
  year: 1959
  ident: 50_CR18
  publication-title: Arch Biochem Biophy
  doi: 10.1016/0003-9861(59)90090-6
– volume: 22
  start-page: 163
  year: 1994
  ident: 50_CR29
  publication-title: Nutr Cancer
  doi: 10.1080/01635589409514341
– volume: 65
  start-page: 439
  year: 1998
  ident: 50_CR14
  publication-title: Ann Thorac Surg
  doi: 10.1016/S0003-4975(97)01297-6
– volume: 1
  start-page: 147
  year: 1972
  ident: 50_CR16
  publication-title: Biochem J
  doi: 10.1042/bj1280147
– volume: 261
  start-page: 3060
  year: 1986
  ident: 50_CR24
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)35746-0
– volume: 84
  start-page: 392
  year: 1999
  ident: 50_CR15
  publication-title: Cir Res
  doi: 10.1161/01.RES.84.4.392
– volume-title: New York: Oxford University Press Inc
  year: 1989
  ident: 50_CR31
– volume: 80
  start-page: 249
  year: 1974
  ident: 50_CR1
  publication-title: Ann Intern Medicine
  doi: 10.7326/0003-4819-80-2-249
– volume: 28
  start-page: 1063
  issue: 9
  year: 1994
  ident: 50_CR7
  publication-title: Ann Pharmacother
  doi: 10.1177/106002809402800912
– volume: 88
  start-page: 5360
  year: 1991
  ident: 50_CR32
  publication-title: Proc Nat Acad Sci
  doi: 10.1073/pnas.88.12.5360
– volume: 81
  start-page: 627
  year: 1997
  ident: 50_CR33
  publication-title: Circ Res
  doi: 10.1161/01.RES.81.4.627
– volume: 276
  start-page: 65
  year: 1995
  ident: 50_CR9
  publication-title: J Mol Cell cardiol
  doi: 10.1016/S0022-2828(08)80008-9
– start-page: 673
  volume-title: In: Methods of Enzymatic Analysis
  year: 1974
  ident: 50_CR19
  doi: 10.1016/B978-0-12-091302-2.50032-3
– volume: 91
  start-page: 10
  issue: 1
  year: 1995
  ident: 50_CR10
  publication-title: Circulation
  doi: 10.1161/01.CIR.91.1.10
– volume: 10
  start-page: 53
  issue: suppl-1
  year: 1983
  ident: 50_CR5
  publication-title: Semin Oncol
– volume: 70
  start-page: 1509
  issue: 13
  year: 2002
  ident: 50_CR12
  publication-title: Life Sciences
  doi: 10.1016/S0024-3205(01)01514-4
– volume: 65
  start-page: 1957
  year: 1987
  ident: 50_CR26
  publication-title: Can J Physiol Pharmacol
  doi: 10.1139/y87-305
– volume: 2
  start-page: 16
  year: 2002
  ident: 50_CR13
  publication-title: BMC Pharmacol
  doi: 10.1186/1471-2210-2-16
– volume: 336
  start-page: 1066
  issue: 15
  year: 1997
  ident: 50_CR36
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199704103361506
– volume: 21
  start-page: 130
  year: 1984
  ident: 50_CR20
  publication-title: Ind J Biochem Biophys
– volume: 79
  start-page: 162
  issue: 2
  year: 1996
  ident: 50_CR35
  publication-title: Circ Res
  doi: 10.1161/01.RES.79.2.162
– volume: 22
  start-page: 698
  issue: 7
  year: 1999
  ident: 50_CR6
  publication-title: Biol Pharm Bull
  doi: 10.1248/bpb.22.698
– reference: 9577950 - Circulation. 1998 Apr 14;97(14):1382-91
– reference: 3456345 - J Biol Chem. 1986 Mar 5;261(7):3060-7
– reference: 10066673 - Circ Res. 1999 Mar 5;84(4):392-400
– reference: 7760384 - J Mol Cell Cardiol. 1995 Jan;27(1):65-74
– reference: 6340204 - Semin Oncol. 1983 Mar;10(1 Suppl 1):53-5
– reference: 9718077 - Life Sci. 1998;63(7):511-21
– reference: 10443465 - Biol Pharm Bull. 1999 Jul;22(7):698-702
– reference: 7803884 - Ann Pharmacother. 1994 Sep;28(9):1063-72
– reference: 1377736 - J Histochem Cytochem. 1992 Aug;40(8):1203-10
– reference: 11895102 - Life Sci. 2002 Feb 15;70(13):1509-18
– reference: 8368352 - Am J Physiol. 1993 Aug;265(2 Pt 2):H484-93
– reference: 8755992 - Circ Res. 1996 Aug;79(2):162-73
– reference: 3690411 - Can J Physiol Pharmacol. 1987 Sep;65(9):1957-65
– reference: 9091804 - N Engl J Med. 1997 Apr 10;336(15):1066-71
– reference: 8371168 - J Pharmacol Exp Ther. 1993 Sep;266(3):1699-704
– reference: 7805190 - Circulation. 1995 Jan 1;91(1):10-5
– reference: 12182765 - BMC Pharmacol. 2002 Aug 16;2:16
– reference: 9485242 - Ann Thorac Surg. 1998 Feb;65(2):439-43
– reference: 14502845 - Nutr Cancer. 1994;22(2):163-73
– reference: 2052612 - Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5360-3
– reference: 11401411 - Pharmacol Res. 2001 Mar;43(3):211-8
– reference: 667860 - Cancer Treat Rep. 1978 Jun;62(6):865-72
– reference: 6490072 - Indian J Biochem Biophys. 1984 Apr;21(2):130-2
– reference: 36810 - Anal Biochem. 1979 Jun;95(2):351-8
– reference: 5085551 - Biochem J. 1972 Jun;128(1):147-59
– reference: 13650640 - Arch Biochem Biophys. 1959 May;82(1):70-7
– reference: 10874342 - Indian J Physiol Pharmacol. 1998 Oct;42(4):440-52
– reference: 7329310 - Methods Enzymol. 1981;77:325-33
– reference: 4590654 - Ann Intern Med. 1974 Feb;80(2):249-59
– reference: 6295497 - Biochim Biophys Acta. 1982 Nov 12;713(2):333-43
– reference: 9314845 - Circ Res. 1997 Oct;81(4):627-35
– reference: 7598835 - Boll Chim Farm. 1995 Feb;134(2):69-76
SSID ssj0017847
Score 1.954319
Snippet Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart...
BACKGROUND: Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes...
SourceID pubmedcentral
biomedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 16
SubjectTerms Animals
Antioxidants - physiology
Body Weight
Cardiomyopathies - chemically induced
Cardiomyopathies - pathology
Cardiomyopathies - prevention & control
Catalase - metabolism
Doxorubicin - adverse effects
Garlic - chemistry
Gene Expression - drug effects
Gene Silencing - drug effects
Glutathione - metabolism
Myocardium - metabolism
Organ Size
Plant Preparations - therapeutic use
Probucol - therapeutic use
Rats
Superoxide Dismutase - metabolism
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - metabolism
Title Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression
URI https://www.ncbi.nlm.nih.gov/pubmed/14687418
https://www.proquest.com/docview/71576179
http://dx.doi.org/10.1186/1471-2210-3-16
https://pubmed.ncbi.nlm.nih.gov/PMC324401
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgbNig8h4exQtUNjUkTvxIJYQQYlQhtRqhGak7y3bsNlKa0OlUmnwCn8OP8E1cJxlCOrBhGdlOFN-3fHwuQq8ZlFuMZjmJPbUk1TIlBqI0yQSzUS6SRLfdG45P-NEi_XLKTgf8U7-BV38t7UI_qcWyfLu-bD6Awb9vDV7ydzE4WEJpcCgk5rfRHYhKIhjpcTqcKAhwwz1p4_aaQB2achmYXG5cfC_H8WorCb2JpfwjOE130b0-q8QfOzW4j2656gHan3W01M0Bng-3rK4O8D6eDYTVzUP0fdaRNYCIsD7TBWSMWNvrlcM6B_28aGxREajdQQtybFsA66peFxYSeGwafKaXZWEP8de6dLj22FV53VG_Yh2wlOsiD2AbeMhxUZ0XpkWJhZnzkyn5-QO7dY_GrR6hxfTz_NMR6Vs0EJMwyQn4B5_HTtPcZ4yxxHPvjYhyyRPHhDCCWpEalmRcU-d5lnkfydQxL73Pksgkj9FOVVfuKcLgdA2jjmZcQtHpmIREKeZZGllnmNN8gg5HglHfOjoOFQiyxyNgqyoIWAUBq0TFsJhspKhsT34eenCUqi2CJN-a_-b3_M13_jXz1UYpFFhmOG7RlYMtViKGWg783QQ96VRkeFOvaxPER8oz-qXxSFWct9zfkP9CRfzsfxc-R3c7NCIF9_gC7ayW1-4lZFUrsxdiGttrjeYXsGsmzg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protection+against+acute+adriamycin-induced+cardiotoxicity+by+garlic%3A+Role+of+endogenous+antioxidants+and+inhibition+of+TNF-%CE%B1+expression&rft.jtitle=BMC+pharmacology&rft.au=Mukherjee%2C+Sumanta&rft.au=Banerjee%2C+Sanjay+Kumar&rft.au=Maulik%2C+Mohua&rft.au=Dinda%2C+Amit+Kumar&rft.date=2003-12-20&rft.pub=BioMed+Central&rft.eissn=1471-2210&rft.volume=3&rft.spage=16&rft.epage=16&rft_id=info:doi/10.1186%2F1471-2210-3-16&rft_id=info%3Apmid%2F14687418&rft.externalDocID=PMC324401
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2210&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2210&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2210&client=summon